Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According to Baseline Biomarker Status, and Change from Baseline in the Fraction of Exhaled Nitric Oxide #EBM#PCC#Asthma#Tezepelumab#NEJM
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
